Pioneering liver treatment cures British baby

November 15, 2011

British doctors on Tuesday said they had cured a baby boy of a life-threatening liver disease using a pioneering treatment in which cells are injected into the abdomen.

The team from London's King's College Hospital treated eight-month old Iyaad Syed by injecting him with a group of cells, which acted as a temporary liver while his real organ recovered from damage caused by a virus, BBC reported.

"This is the first time this treatment has been used to treat a child with ," said professor Anil Dhawan, a liver specialist at the hospital.

"It's only a few months back when I first saw this child who was so sick requiring support on dialysis and a breathing machine.

"We think we have given him another chance of life and seeing him now six months down the road with nearly normal is remarkable."

Syed would normally have been put on the transplant waiting list when his liver began to fail, but the hope now is that more cases will be cured using the new technique rather than relying on a scarce supply of donor organs.

Doctors injected which then processed toxins and produced proteins, fulfilling the role of a temporary liver while his own began to recover two weeks later.

The cells were treated with a chemical to prevent them from being destroyed by the youngster's immune system.

Iyaad's father, Jahangeer, called his son "a miracle boy", adding "it is brilliant and we are very proud of him."

The treatment's development now depends on an extensive clinical trial.

Andrew Langford, Chief Executive of the British Liver Trust, told the BBC: "The principle of this new technique is certainly ground-breaking and we would welcome the results of further clinical trials to see if it could become a standard treatment for both adults and children.

"Sadly, we have reached a with our transplant list in the UK, where approximately 100 people die waiting for a to become available each year."

Explore further: Medical center performs rare, double living donor organ transplant

Related Stories

Medical center performs rare, double living donor organ transplant

May 3, 2011
Transplant surgeons at Penn State Milton S. Hershey Medical Center recently performed their first simultaneous, dual living donor organ transplant on a single recipient. The recipient, a 60-year-old man from the Hazleton ...

Recommended for you

Creation of synthetic horsepox virus could lead to more effective smallpox vaccine

January 19, 2018
UAlberta researchers created a new synthetic virus that could lead to the development of a more effective vaccine against smallpox. The discovery demonstrates how techniques based on the use of synthetic DNA can be used to ...

Study ends debate over role of steroids in treating septic shock

January 19, 2018
The results from the largest ever study of septic shock could improve treatment for critically ill patients and save health systems worldwide hundreds of millions of dollars each year.

New approach could help curtail hospitalizations due to influenza infection

January 18, 2018
More than 700,000 Americans were hospitalized due to illnesses associated with the seasonal flu during the 2014-15 flu season, according to federal estimates. A radical new approach to vaccine development at UCLA may help ...

Zika virus damages placenta, which may explain malformed babies

January 18, 2018
Though the Zika virus is widely known for a recent outbreak that caused children to be born with microencephaly, or having a small head, and other malformations, scientists have struggled to explain how the virus affects ...

Certain flu virus mutations may compensate for fitness costs of other mutations

January 18, 2018
Seasonal flu viruses continually undergo mutations that help them evade the human immune system, but some of these mutations can reduce a virus's potency. According to new research published in PLOS Pathogens, certain mutations ...

Study reveals how MRSA infection compromises lymphatic function

January 17, 2018
Infections of the skin or other soft tissues with the hard-to-treat MRSA (methicillin-resistant Staphylococcus aureus) bacteria appear to permanently compromise the lymphatic system, which is crucial to immune system function. ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

grgfraiser
not rated yet Nov 15, 2011
could they create a whole replacement for people who cant repair their own liver

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.